April 3, 2022
Video

ACC 2022: VALOR-HCM - Mavacamten As An Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

Video Player is loading.
Current Time 0:00
Duration 9:17
Loaded: 0%
Stream Type LIVE
Remaining Time 9:17
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected

09:17

C. Michael Gibson and Milind Desai discuss the VALOR-HCM results presented at ACC 2022.